Skin Diseases  >>  Tremfya (guselkumab)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Tremfya (guselkumab) / J&J
NCT00925574: A Study of the Safety and How the Body Affects a Drug (CNTO 1959) in Healthy Volunteers and in Patients With Psoriasis

Completed
1
71
US
CNTO 1959; Placebo
Centocor, Inc.
Psoriasis
10/10
10/10
NCT01484587: A Study of the Safety, Tolerability, Pharmacokinetics (What the Body Does to the Drug), and Pharmacodynamics (What the Drug Does to the Body) of CNTO 1959 Following a Single Subcutaneous (Under the Skin) Administration in Japanese Participants With Moderate to Severe Plaque Psoriasis

Checkmark Moderate to severe psoriasis
Apr 2014 - Apr 2014: Moderate to severe psoriasis
Completed
1
24
Japan
CNTO 1959, Placebo
Janssen Pharmaceutical K.K.
Psoriasis
04/13
04/13

Download Options